Since January 2021, Russia has exported $303.6 million worth of vaccines for humans, which is 32 times more than in 2020, and almost twice as much as since 2018, RBC reports. It is clarified that in the first five months of 2021, Russia sold almost twice as many vaccines abroad in value terms than in the previous three years in total. According to the Federal Customs Service, 159 tonnes of pharmaceutical products were delivered to other countries from January to May 2021.
As follows from the data of the Federal Customs Service (FCS) of the Russian Federation, in 2021, Argentina, Kazakhstan, India, Mexico, Hungary, Belarus, the United Arab Emirates, Serbia, Bolivia, and the Democratic Republic of the Congo became the main export partners of Russian manufacturers and accounted for 85.8 per cent of all shipments for the five months of this year.
It is noted that Argentina became one of the first countries to sign a contract for the supply of “Sputnik V” produced by the N. F. Gamaleya National Centre of Epidemiology and Microbiology. The government of the country has agreed with the Direct Investment Fund (RDIF) to supply 20 million doses of the Russian vaccine at the end of 2020.
Even though RBC claims that the FCS data does not allow accurately determining the cost of the COVID-19 vaccine sent abroad, from public reports of representatives of countries and procurement documents from several states it follows that the cost of the vaccine varies. For example, a member of the upper chamber of the Belarusian parliament, Mikhail Rusy, said that the cost of two doses of Sputnik V vaccine costs the state $40, Kazakhstan buys it at $26, Hungary and Slovakia at $19.90 ($9.95 for one component), and pilot vaccine shipments to India were priced at $13.58.